88019-89-0

Basic information

• Product Name: 7-iodoheptanoic acid
• CAS NO: 88019-89-0
• Molecular Formula: C₇H₁₃IO₂
• Molecular Weight: 256.0814
• Mol File: 88019-89-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 297.6°C at 760 mmHg
• Flash Point: 133.8°C
• Density: 1.625g/cm³
• Vapor Pressure: 0.000319mmHg at 25°C
• Refractive Index: 1.534
• CAS DataBase Reference: 7-iodoheptanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-iodoheptanoic acid(88019-89-0)
• EPA Substance Registry System: 7-iodoheptanoic acid(88019-89-0)

Safety Data

• Hazardous Substances Data: 88019-89-0(Hazardous Substances Data)

Upstream product

• 821-57-8 7-chloroheptanoic acid 
• 539-87-7 oxocan-2-one 
• 75-77-4 chloro-trimethyl-silane 

Downstream Products

• 92016-00-7 10-hydroxydec-8-ynoic acid 
• 539-87-7 oxocan-2-one 
• 54005-76-4 tert-butyl 7-iodoheptanoate 

Relevant articles and documents

LIPID PRODRUGS OF NEUROSTEROIDS

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.

LIPID PRODRUGS OF PREGNANE NEUROSTEROIDS AND USES THEREOF

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, as well as methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.

LIPID PRODRUGS OF GLUCOCORTICOIDS AND USES THEREOF

The present invention provides lymphatic system-directing lipid prodrugs, pharmaceutical compositions thereof, methods of producing such prodrugs and compositions, and methods of improving the bioavailability or other properties of a therapeutic agent that comprises part of the lipid prodrug. The present invention also provides methods of treating a disease, disorder, or condition such as those disclosed herein, comprising administering to a patient in need thereof a disclosed lipid prodrug or a pharmaceutical composition thereof.